|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Dice Therapeutics, Inc. (DICE) |
|
|
$47.55 0.00 (0.00%) as of 4:30 Tue 8/8
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
54,759,000 |
| Market
Cap: |
2.60(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$30.03 - $47.55 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile DICE Therapeutics is a a biopharmaceutical company using its proprietary technology platform, DELSCAPE, to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DELSCAPE is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs). Co.'s lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in immunology indications. Co. is also developing oral therapeutic for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,647,701 |
| Total Buy Value |
$0 |
$0 |
$0 |
$88,116,065 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
7 |
| Total Shares Sold |
0 |
0 |
2,638,166 |
2,666,152 |
| Total Sell Value |
$0 |
$0 |
$121,279,876 |
$122,111,370 |
| Total People Sold |
0 |
0 |
6 |
7 |
| Total Sell Transactions |
0 |
0 |
6 |
10 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shah Rajeev M. |
Director |
– • • |
2023-03-30 |
4 |
B |
$28.74 |
$5,632,954 |
I/I |
195,997 |
7,070,205 |
2.25 |
66% |
|
| Shah Rajeev M. |
Director |
– • • |
2023-03-29 |
4 |
B |
$29.38 |
$1,949,921 |
I/I |
66,369 |
6,874,208 |
2.25 |
62% |
|
| Jacobsen John R. |
CSO |
• – – |
2023-03-29 |
4 |
AS |
$30.00 |
$32,823 |
D/D |
(1,094) |
183,412 |
|
62% |
|
| Shah Rajeev M. |
Director |
– • • |
2023-03-28 |
4 |
B |
$29.24 |
$7,215,818 |
I/I |
246,779 |
6,807,839 |
2.25 |
61% |
|
| Jacobsen John R. |
CSO |
• – – |
2023-03-28 |
4 |
AS |
$30.09 |
$15,044 |
D/D |
(500) |
184,506 |
|
61% |
|
| Shah Rajeev M. |
Director |
– • • |
2023-03-27 |
4 |
B |
$27.48 |
$4,153,107 |
I/I |
151,132 |
6,561,060 |
2.25 |
72% |
|
| Shah Rajeev M. |
Director |
– • • |
2023-03-24 |
4 |
B |
$26.87 |
$5,168,041 |
I/I |
192,335 |
6,409,928 |
2.25 |
74% |
|
| Shah Rajeev M. |
Director |
– • • |
2023-03-23 |
4 |
B |
$26.67 |
$4,136,224 |
I/I |
155,089 |
6,217,593 |
2.25 |
77% |
|
| Scopa James Paul |
Director |
– • – |
2023-03-17 |
4 |
S |
$29.05 |
$290,500 |
I/I |
(10,000) |
23,719 |
|
-63% |
|
| Scopa James Paul |
Director |
– • – |
2022-10-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,719 |
33,719 |
|
- |
|
| Scopa James Paul |
Director |
– • – |
2022-10-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,719 |
22,122 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2022-10-17 |
4 |
B |
$36.50 |
$59,860,000 |
I/I |
1,640,000 |
6,848,911 |
2.25 |
-12% |
|
| Rubin Michael P. |
10% Owner |
– – • |
2021-09-17 |
4 |
B |
$17.00 |
$3,995,000 |
I/I |
235,000 |
3,292,871 |
1.5 |
-57% |
|
| Rubin Michael P. |
10% Owner |
– – • |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,057,871 |
3,057,871 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2021-09-17 |
4 |
B |
$17.00 |
$23,800,000 |
I/I |
1,400,000 |
786,407 |
2.25 |
-57% |
|
| Shah Rajeev M. |
Director |
– • • |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,808,911 |
708,829 |
|
- |
|
| Scopa James Paul |
Director |
– • – |
2021-09-15 |
4 |
B |
$17.00 |
$102,000 |
D/D |
6,000 |
55,841 |
2.39 |
- |
|
| Scopa James Paul |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,000 |
|
- |
|
| Robertson Scott M. |
CFO & CBOOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
284,600 |
|
- |
|
| Tetlow Sharon |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,000 |
|
- |
|
| Judice Kevin |
CEOOfficer |
• • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
971,644 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
113,000 |
|
- |
|
| Jacobsen John R. |
CSOOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
231,625 |
|
- |
|
| Timothy Lu |
CMOOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
215,835 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
